-
Truxima®
Living with a chronic autoimmune or inflammatory condition can take a toll on both physical health and everyday life. Persistent symptoms, flare-ups, and fatigue can interfere with work, relationships, and overall well-being. At Singlepoint Healthcare, we provide Truxima® IV therapy as part of a comprehensive, individualized approach to managing immune-mediated conditions.
How Truxima Works
Truxima® (rituximab-abbs) is a biologic infusion therapy that targets specific immune cells involved in chronic inflammation and autoimmune activity. It is a biosimilar to rituximab and is designed to deliver the same clinical effectiveness and safety profile while expanding access to advanced treatment options.
Truxima® is commonly used to manage autoimmune and inflammatory conditions in which the immune system mistakenly attacks healthy tissues. By selectively reducing overactive immune cells, Truxima® helps decrease inflammation, slow disease progression, and improve symptom control over time.
Key Details
Important Information
| Category | Details |
|---|---|
| Conditions It Treats | Non-Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL) |
| Manufacturer | Celltrion |
| Administered by | Infusion |
| Frequency | Varies by diagnosis and treatment plan |
| Length of Infusion | Several hours |
| FDA Approval(s) | Non-Hodgkin's Lymphoma (NHL): November 28. 2018 Chronic Lymphocytic Leukemia (CLL): May 2019 |